AIMT - Aimmune Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $18.36. This is a potential upside of $18.36 (0%) from yesterday's end of day stock price of $0.

Aimmune Therapeutics's activity chart (see below) currently has 111 price targets and 79 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.28% with an average time for these price targets to be met of 126.62 days.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 01-Sep-2020. First documented stock forecast 17-Nov-2015.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

18

3 years 6 months ago

4/4 (100%)

$3.19 (21.54%)

176

Hold

34.5

$0.01 (0.03%)

66

3 years 5 months 30 days ago

1/8 (12.5%)

$0.28 (0.82%)

39

Hold

34.5

$0.01 (0.03%)

14

3 years 5 months 30 days ago

7/7 (100%)

$0.28 (0.82%)

105

Hold

35

$0.51 (1.48%)

24

3 years 5 months 30 days ago

7/17 (41.18%)

$0.78 (2.28%)

376

Buy

50

$15.51 (44.97%)

50

3 years 6 months 5 days ago

0/5 (0%)

$37.24 (291.85%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AIMT (Aimmune Therapeutics) average time for price targets to be met?

On average it took 126.62 days on average for the stock forecasts to be realized with a an average price target met ratio 30.28

Which analyst has the current highest performing score on AIMT (Aimmune Therapeutics) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on AIMT (Aimmune Therapeutics)?

Charles Duncan works at CANTOR FITZGERALD and has 9 price targets and 7 ratings on AIMT

Which analyst is the currently most bullish on AIMT (Aimmune Therapeutics)?

Jotin Marango with highest potential upside - $45.51

Which analyst is the currently most reserved on AIMT (Aimmune Therapeutics)?

Paul Choi with lowest potential downside - -$12.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?